DiaMedica Therapeutics Inc. Common Stock

$2.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-8.70%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell DMAC and other stocks, options, ETFs, and crypto commission-free!

About DMAC

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). Read More The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Employees
9
Headquarters
Minneapolis, Minnesota
Founded
2000
Market Cap
362.99M
Price-Earnings Ratio
Dividend Yield
Average Volume
86.44K
High Today
$2.61
Low Today
$2.16
Open Price
$2.60
Volume
46.34K
52 Week High
$10.00
52 Week Low
$2.15

Collections

DMAC Earnings

-$0.27
-$0.25
-$0.23
-$0.21
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.21 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.